Evolus (EOLS) EBITDA (2017 - 2026)

Evolus' EBITDA history runs 10 years deep, the most recent figure standing at -$6.8 million for Q1 2026.

• Quarterly EBITDA rose 54.86% year-over-year to -$6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.3 million (up 40.14% YoY) and the FY2025 annual result came in at -$32.7 million, up 5.08% from the prior year.
• EBITDA was -$6.8 million for Q1 2026 at Evolus, down from $4.2 million in the prior quarter.
• Across five years, EBITDA topped out at $4.2 million in Q4 2025 and bottomed at -$21.3 million in Q2 2022.
• A 5-year average of -$11.1 million and a median of -$11.5 million in 2025 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA plunged 292.47% — and 2025, when it surged 282.37%.
• Evolus' EBITDA stood at -$10.6 million in 2022, then advanced by 18.82% to -$8.6 million in 2023, then surged by 73.2% to -$2.3 million in 2024, then jumped by 282.37% to $4.2 million in 2025, then plunged by 262.27% to -$6.8 million in 2026.
• Business Quant data shows EOLS's EBITDA at -$6.8 million in Q1 2026, $4.2 million in Q4 2025, and -$11.5 million in Q3 2025.